FDA Drug Safety PodcastJuly 23, 2020
For all patients who are prescribed opioid pain relievers, health care professionals should discuss the availability of naloxone (brand names Narcan, Evzio), and consider prescribing it to patients who are at increased risk of opioid overdose, such as patients who are also using benzodiazepines or other medicines that depress the central nervous system, who have a history of opioid use disorder (OUD), or who have experienced a previous opioid overdose. Health care professionals should also consider prescribing naloxone if the patient has household members, including children, or other close contacts at risk for accidental ingestion or opioid overdose.
